10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,434,305 | +126.9% | 204,468 | +207.1% | 0.02% | +100.0% |
| Q2 2023 | $3,717,827 | +84.1% | 66,580 | +83.9% | 0.01% | +175.0% |
| Q1 2023 | $2,019,598 | +313.4% | 36,200 | +170.0% | 0.00% | +100.0% |
| Q4 2022 | $488,478 | -37.1% | 13,405 | +31.4% | 0.00% | -33.3% |
| Q1 2022 | $776,000 | -44.1% | 10,200 | +43.8% | 0.00% | -40.0% |
| Q2 2021 | $1,389,000 | +168.7% | 7,094 | +148.5% | 0.01% | +150.0% |
| Q1 2021 | $517,000 | -60.7% | 2,855 | -69.3% | 0.00% | -66.7% |
| Q4 2020 | $1,317,000 | +2.1% | 9,301 | -10.1% | 0.01% | -14.3% |
| Q3 2020 | $1,290,000 | – | 10,345 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |